Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bannerman, D. D.
Right arrow Articles by Goldblum, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bannerman, D. D.
Right arrow Articles by Goldblum, S. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 52, 35371-35380, December 25, 1998


Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction Proteins*

Douglas D. BannermanDagger , Malathi Sathyamoorthy, and Simeon E. Goldblum§

From the Division of Infectious Diseases, Departments of Pathology and Medicine, Department of Veterans Affairs Medical Center, University of Maryland School of Medicine, Baltimore, Maryland 21201

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Bacterial lipopolysaccharide or endotoxin induces actin reorganization, increased paracellular permeability, and endothelial cell detachment from the underlying extracellular matrix in vitro. We studied the effect of endotoxin on transendothelial albumin flux and detachment of endothelial cells cultured on gelatin-impregnated filters. The endotoxin-induced changes in endothelial barrier function and detachment occurred at doses and times that were compatible with endotoxin-induced apoptosis. Since the actin cytoskeleton and cell-cell and cell-matrix adhesion all participate in the regulation of the paracellular pathway and cell-matrix interactions, we studied whether protein components of the actin-linked adherens junctions were modified in response to endotoxin. Components of cell-cell (beta - and gamma -catenin) and cell-matrix (focal adhesion kinase and p130Cas) adherens junctions were cleaved by caspases activated during apoptosis with dose and time requirements that paralleled those seen for barrier dysfunction and detachment. Cleavage of focal adhesion kinase led to its dissociation from the focal adhesion-associated signaling protein, paxillin, resulting in reduced paxillin tyrosine phosphorylation. Inhibition of caspase-mediated cleavage of these proteins protected against detachment but not opening of the paracellular pathway. Therefore, endotoxin-induced disruption of endothelial monolayer integrity and survival signaling events is mediated, in part, through caspase cleavage of adherens junction proteins.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Gram-negative bacteremia is often complicated by systemic vascular collapse, disseminated intravascular coagulation, and vascular leak syndromes (1-4). One common element to these complications is endothelial cell (EC)1 injury and/or dysfunction. Evidence exists that a constituent of the bacterial cell envelope, endotoxin or lipopolysaccharide (LPS), is responsible for much of the EC injury associated with Gram-negative sepsis (1, 2, 4, 5). Although much of LPS-induced vascular pathophysiology can be explained through host responses to LPS (1), evidence exists for a direct role for LPS (6-9). ECs, which line the vasculature, are the first host tissue barrier seen by circulating LPS, and LPS has been localized to the endothelium (10). Furthermore, in the absence of nonendothelial-derived host mediator systems, LPS directly induces numerous EC responses in vitro (11, 12).

The EC response to LPS includes actin reorganization (6, 8), monolayer barrier dysfunction (8, 9, 13, 14), and cell detachment from the underlying extracellular matrix (ECM) (15, 16). In EC, the actin cytoskeleton is tethered to two distinct adherens junctions, the zonula adherens (ZA) and focal adhesions (FA), which mediate cell-cell and cell-matrix interactions, respectively (17-20). These junctions each contain a transmembrane protein that is linked to the actin cytoskeleton via a multiprotein complex of cytoplasmic structural and signaling proteins. The ZA transmembrane protein, cadherin, which homotypically binds to cadherin molecules on neighboring cells, is linked to the actin cytoskeleton through at least three cytoplasmic proteins, alpha -, beta -, and gamma -catenin (21-23). The integrin family of transmembrane proteins localized to FA binds to the RGD-containing sequence found in certain ECM proteins (24). Integrins are linked to the actin cytoskeleton via a cytoplasmic complex of proteins comprised of vinculin, tensin, talin, alpha -actinin, paxillin, focal adhesion kinase (FAK), and p130Cas (19, 20, 25).

LPS has been shown to induce EC apoptosis both in vivo and in vitro (26-28). In LPS-challenged mice, widespread EC apoptosis, an event which could only be partially blocked by recombinant tumor necrosis factor alpha  (TNF-alpha ) binding protein, has been demonstrated (28). LPS also directly induces EC activation of caspases in vitro, in the absence of endogenous mediators derived from non-EC sources, including TNF-alpha (29). Caspases, which are cysteine proteases activated during apoptosis, cleave a limited number of cell proteins including the adherens junction components, beta -catenin, gamma -catenin, and FAK (30-34). In the present report, we have studied the ability of LPS to induce directly EC apoptosis, and we have identified key adherens junction proteins that are cleaved as a result of LPS-induced caspase activation. Since EC monolayer integrity is dependent on intact cell-cell and cell-matrix junctions, we have considered how cleavage of adherens junction proteins contributes to the loss of barrier function and EC detachment. Finally, the impact of FAK cleavage on protein-protein interactions, tyrosine phosphorylation events, and anti-apoptotic signaling was studied.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- The caspase inhibitor peptide, Z-VAD-fluoromethylketone (Z-VAD) and the negative control peptide, Z-FA-fluoromethylketone (Z-FA), were purchased from Calbiochem. LPS phenol-extracted from Escherichia coli serotype 0111:B4, polymyxin B (PMB) sulfate, staphylococcal enterotoxin B (SEB), herbimycin A, and dimethyl sulfoxide (Me2SO) were obtained from Sigma. Recombinant human TNF-alpha (specific activity >= 2 × 107 units/mg) was purchased from Endogen, Inc. (Woburn, MA). Endotoxin-neutralizing protein (ENP) was a gift from the Associates of Cape Cod (Woodshole, MA).

EC Culture-- Bovine pulmonary artery ECs (American Type Culture Collection, Rockville, MD) were cultured in Dulbecco's modified Eagle's medium (Sigma) enriched with 20% fetal bovine serum (FBS) (HyClone Laboratories), L-glutamine (5 mM), nonessential amino acids, and vitamins in the presence of penicillin (50 units/ml) and streptomycin (50 µg/ml) (Sigma) as described (8, 9). Only cells from passages two through seven were studied.

Assay of Transendothelial Albumin Flux-- Transendothelial [14C]bovine serum albumin (BSA) flux was assayed as described (6-9). ECs (2 × 105 cells/chamber) were cultured for 72 h on gelatin-impregnated polycarbonate filters (13-mm diameter, 0.4-µm pore size) (Nuclepore Inc., Pleasanton, CA) mounted in polystyrene chemotactic chambers (ADAPS, Inc., Dedham, MA) inserted into the wells of 24-well plates. The base-line barrier function of each monolayer was determined by applying an equivalent and reproducible amount of tracer molecule, [14C]BSA (1.1 pmol/0.5 ml; Sigma), to each upper compartment for 1 h at 37 °C, after which the lower compartment was counted for 14C activity. Only EC monolayers retaining >= 97% of the tracer were then treated and again assayed for transendothelial [14C]BSA flux.

Filter Detachment Assay-- Gelatin-impregnated polycarbonate filters (25-mm diameter, 0.4-µm pore size) (Nuclepore) were mounted in chemotactic chambers (ADAPS) that were inserted into the wells of 6-well plates. The chambers were seeded with 3.5 × 105 EC and cultured for 72 h. Following treatment, the supernatant and one wash from each well were pooled and the cells counted in triplicate. The remaining monolayer was trypsin-detached (0.5 mg/ml, 15 min) and the cells counted. Filters were stained with Coomassie Brilliant Blue to document complete cell detachment. Percent detachment was expressed as (total cells in the supernatant and wash)/(total cells in supernatant, wash, and detached from filter) × 100%.

Immunoblotting of Adherens Junction Proteins-- Confluent EC monolayers were washed with ice-cold phosphate-buffered saline containing 1 mM sodium orthovanadate, lysed with ice-cold modified radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, protease inhibitor mixture tablet (Boehringer Mannheim), 1 µg/ml pepstatin, 1 µg/ml type 1 DNase, 1 mM vanadate, 50 mM NaF), scraped, transferred to microcentrifuge tubes, and centrifuged (16,000 × g, 10 min, 4 °C). The supernatants (20 µg of protein/lane) were resolved by SDS-PAGE on an 8-16% Tris glycine gradient gel (Novex Inc., San Diego, CA) and transferred to polyvinylidene fluoride membrane (Millipore Corp., Bedford, MA). Blots were blocked with 3% dry milk and then incubated with anti-alpha -catenin (1.0 µg/ml), anti-beta -catenin (0.5 µg/ml), anti-gamma -catenin (0.13 µg/ml), anti-focal adhesion kinase (FAK) (0.25 µg/ml), anti-p120Cas (0.3 µg/ml), anti-p130Cas (0.25 µg/ml) (all purchased from Transduction Laboratories Inc., Lexington, KY), anti-beta -catenin NH2 terminus (1:5000 dilution; generous gift of Dr. Barry M. Gumbiner of the Memorial Sloan-Kettering Cancer Center), or anti-pan cadherin (6.6 µg/ml; Sigma) antibodies for 1 h. The blots were incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulin G (IgG) (0.13 µg/ml; Transduction Labs), developed with enhanced chemiluminescence (Amersham Pharmacia Biotech), and exposed to Kodak X-Omat Blue film (NEN Life Science Products). To ensure equal protein loading, the blots were stained with Fast Green (Sigma) and then stripped with 100 mM 2-mercaptoethanol, 2% sodium dodecyl sulfate, 62.5 mM Tris-HCl (pH 6.7) at 70 °C for 30 min, washed, blocked, and reprobed with anti-beta -tubulin murine monoclonal antibody (0.5 µg/ml; Boehringer Mannheim) followed by horseradish peroxidase-conjugated anti-mouse IgG (0.13 µg/ml) (Transduction Labs).

Immunoprecipitation (IP) of Adherens Junction Proteins-- EC were lysed with modified RIPA buffer and the lysates incubated overnight at 4 °C with anti-pan cadherin, anti-alpha -catenin, anti-APC (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or anti-paxillin antibodies (2.5 µg of antibody/500 µg of total protein). The resultant immune complexes were immobilized by incubation with either anti-mouse or anti-rabbit IgG cross-linked to agarose (Sigma) for 2 h at 4 °C and centrifuged. The pellet was washed three times with modified RIPA buffer, boiled in 2× sample buffer (5× sample buffer: 62.5 mM Tris-HCl (pH 6.8), 2.5% SDS, 25% glycerol, 1% beta -mercaptoethanol, and 0.1% bromphenol blue), and immunoblotted as described above. In other experiments, blots of EC paxillin immunoprecipitates were incubated for 1 h with a biotinylated 4G10 anti-phosphotyrosine antibody (0.7 µg/ml; Upstate Biotechnology Inc., Lake Placid, NY) followed by horseradish peroxidase-conjugated streptavidin (0.5 µg/ml; Upstate Biotechnology Inc.). To monitor efficiency of IP and protein loading, blots containing paxillin immunoprecipitates were stripped and reprobed with anti-paxillin antibody (0.025 µg/ml; Transduction Labs). The blots were analyzed by laser densitometry (Molecular Dynamics Corp., Sunnyvale, CA), and the phosphotyrosine signal was normalized to paxillin. The relative amount of paxillin tyrosine phosphorylation following LPS exposure was expressed relative to the simultaneous medium controls. For those monolayers exposed to LPS (100 ng/ml; 6 h) in the presence of the Z-VAD caspase inhibitor, the relative amount of paxillin tyrosine phosphorylation was expressed relative to that detected in EC exposed to Z-VAD alone.

Detection of Apoptosis-- LPS-induced EC apoptosis was assayed by both DNA laddering and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling) assays (35). To assess DNA laddering, EC harvested with a cell scraper from treated monolayers were centrifuged (200 × g, 5 min) and resuspended in 200 µl of phosphate-buffered saline. DNA was isolated using the Apoptotic DNA Ladder kit (Boehringer Mannheim). Isolated DNA was incubated with RNase, DNase-free (2 µg/ml, 20 min, room temperature; Boehringer Mannheim), and 2 µg of DNA was resolved on a 2% agarose gel containing 0.5 µg/ml ethidium bromide. DNA in the gel was visualized by ultraviolet (UV) light and photographed with Polaroid positive/negative film (Polaroid Corp., Cambridge, MA).

For the TUNEL assay, ECs cultured in the wells of chamber slides (Nalge Nunc International Corp., Naperville, IL) were treated, fixed in 4% paraformaldehyde, and permeabilized (0.1% Triton X-100, 0.1% sodium citrate; 3 min at 4 °C). Each well was exposed to 100 µl of TUNEL reaction mixture (Boehringer Mannheim) in a humidified chamber for 1 h at 37 °C in the dark. The slides were rinsed and mounted with anti-fade mounting medium (Vector Laboratories Inc., Burlingame CA) under glass coverslips. The monolayers were photographed through a Zeiss Axioscop 20 microscope (× 100 oil, 1.3 N.A., Plan Neofluar objective). For phase contrast microscopy, ECs were visualized through a Zeiss inverted microscope (× 10, 0.25 N.A., F-Achromat PH1 objective).

Statistical Methods-- For time-dependent measurements (transendothelial albumin flux, filter detachment assays, and relative state of paxillin tyrosine phosphorylation), the mean response for each experimental group was compared with its respective control utilizing the Student's t test. For other measurements, analyses of variance was used to compare the mean responses among experimental and control groups. The Tukey post hoc comparison test was used to determine between which groups significant differences existed. For all statistical methods employed, a p value of <0.05 was considered significant.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Dose- and Time-dependent Effect of LPS on Transendothelial [14C]BSA Flux and EC Detachment-- LPS exposure for 6 h increased transendothelial [14C]BSA flux in a dose-dependent manner (Fig. 1A). The mean (±S.E.) pretreatment transendothelial [14C]BSA flux was 0.017 ± 0.001 pmol/h (n = 94), and the mean (±S.E.) [14C]BSA transfer across naked filters without endothelial monolayers was 0.215 ± 0.015 pmol/h (n = 16). LPS at concentrations >= 1 ng/ml increased [14C]BSA flux compared with the simultaneous medium control. The LPS-induced effect appeared to plateau at concentrations of >= 100 ng/ml. The LPS effect on endothelial barrier function was also time-dependent (Fig. 1B). LPS exposures (10 ng/ml) of >= 2 h increased [14C]BSA flux compared with the simultaneous medium control. For the EC detachment studies, the mean (±S.E.) total cell counts (supernatant + wash + filter) from LPS-exposed monolayers and media controls were not significantly different at all time points tested (data not shown). The mean (±S.E.) percent detachment for cells exposed for 6 h to LPS >= 10 ng/ml was increased compared with the simultaneous medium controls (Fig. 1C); at 1 ng/ml the LPS effect approached but did not reach statistical significance (p = 0.0748). The mean (±S.E.) percent detachment of cells exposed to LPS 10 ng/ml was increased at >= 2 h compared to the simultaneous medium controls (Fig. 1D). Therefore, endothelial barrier dysfunction and EC detachment could be each induced by comparable LPS concentrations and exposure times.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 1.   Dose- and time-dependent effect of LPS on transendothelial [14C]BSA flux and EC detachment. Vertical bars represent mean (±S.E.) transendothelial [14C]BSA flux in pmol/h (A and B) or percent EC detachment from gelatin-impregnated filters (C and D) immediately after a 6-h exposure to increasing concentrations of LPS (A and C), or after increasing exposure times to a fixed concentration of LPS (10 ng/ml) or medium alone (B and D). n for each experimental condition is notated within each bar. * = significantly increased compared with the simultaneous medium control.

Dose- and Time-dependent Effect of LPS-induced EC Apoptosis-- LPS exposure for 4 h induced apoptosis in a dose-dependent manner as assayed by DNA fragmentation into multiples of approximately 180 base pairs (bp) (Fig. 2A). DNA fragmentation was observed at LPS concentrations >= 1 ng/ml. The LPS-induced effect appeared to plateau at concentrations of >= 30 ng/ml. LPS-induced apoptosis was also time-dependent (Fig. 2B). DNA laddering was observed at LPS exposures (100 ng/ml) of >= 2 h.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 2.   LPS-induced EC DNA fragmentation. EC were incubated with either increasing concentrations of LPS for 6 h (A) or a fixed concentration of LPS (100 ng/ml) (+) or medium alone (-) for increasing exposure times (B). EC DNA was isolated and subjected to gel electrophoresis in a 2% agarose gel stained with ethidium bromide. Bands were visualized with UV light. DNA molecular weight markers, expressed as bp, are indicated to the left of each gel. Each gel is representative of three separate experiments.

Dose- and Time-dependent Effect of LPS-induced Cleavage of ZA and FA Component Proteins-- After establishing that LPS induces EC apoptosis and that the dose and time requirements for this event were compatible with those for EC barrier function and detachment, adherens junction proteins that mediate cell-cell and cell-substrate adhesion were studied. Western analysis of LPS-exposed EC revealed a dose- and time-dependent cleavage of the ZA proteins, beta -catenin and gamma -catenin (Fig. 3). The other components of the ZA, cadherin, alpha -catenin, and p120Cas, remained intact (Fig. 3). At concentrations >= 3 ng/ml, 6-h LPS exposures induced proteolysis of both beta -catenin and gamma -catenin (Fig. 3A). Furthermore, LPS exposure (100 ng/ml) times of >= 2 h were required for the cleavage events (Fig. 3B). beta -Catenin cleavage generated a 70-kDa fragment; gamma -catenin was cleaved into two distinct fragments of 74 and 64 kDa. The 74 kDA gamma -catenin cleavage product appeared at lower LPS concentrations than the 64-kDa product. The FA proteins, FAK and p130Cas, were similarly cleaved in a dose- (Fig. 4A) and time-dependent (Fig. 4B) manner. Proteolysis of FAK and p130Cas generated 96- and 33-kDa cleavage products, respectively. Two other FA proteins, paxillin and talin, remained intact, and their relative abundance did not change (data not shown). The relative abundance of the cytoskeletal protein, beta -tubulin, remained constant throughout the LPS exposure (Fig. 4, A and B).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   Dose- and time-dependent effect of LPS on cleavage of ZA component proteins. EC were incubated with either increasing concentrations of LPS for 6 h (A) or a fixed concentration of LPS (100 ng/ml) (+) or medium alone (-) for increasing exposure times (B). EC lysates were immunoblotted with antibodies raised against cadherin, p120Cas, alpha -catenin, beta -catenin, or gamma -catenin. Molecular mass (in thousands) is indicated by arrows to the right. Each blot is representative of three separate experiments.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 4.   Dose- and time-dependent effect of LPS on cleavage of FA component proteins. EC were incubated with either increasing concentrations of LPS for 6 h (A) or a fixed concentration of LPS (100 ng/ml) (+) or medium alone (-) for increasing exposure times (B). EC lysates were immunoblotted with anti-p130Cas or anti-FAK antibodies and then stripped and reprobed for beta -tubulin. Molecular mass (in thousands) is indicated by arrows to the right. Each blot is representative of three separate experiments.

Caspase Inhibition Blocks LPS-induced Protein Cleavage and Apoptosis-- The caspase inhibitor peptide, Z-VAD (36, 37), was tested for its ability to block LPS-induced cleavage of adherens junction proteins. The peptide inhibited LPS-induced cleavage of beta -catenin, gamma -catenin, FAK, and p130Cas in a dose-dependent manner at concentrations of >= 12.5 µM; almost complete inhibition was seen with 100 µM Z-VAD (Fig. 5A and data not shown). The generation of the 64-kDa gamma -catenin fragment was blocked at lower concentrations of the caspase inhibitor than the 74-kDa fragment. A negative control peptide (Z-FA) which inhibits the cysteine protease, cathepsin B (38), failed to completely block LPS-induced cleavage of beta -catenin and FAK. Although it appeared to block the generation of the 64-kDa fragment of gamma -catenin, it had no inhibitory effect on the generation of the 74-kDa fragment. Since Z-VAD could block LPS-induced protein cleavage, the ability of this peptide to block LPS-evoked apoptosis was assessed by two independent assays, DNA laddering (Fig. 5B) and TUNEL (Fig. 5C). LPS-induced (100 ng/ml, 4 h) EC DNA fragmentation was completely blocked by the Z-VAD (100 µM) peptide (Fig. 5B). The ability of this peptide to inhibit LPS-induced apoptosis was confirmed by the TUNEL assay (Fig. 5C). Visualization with fluorescence microscopy of EC exposed to LPS (100 ng/ml, 4 h) revealed cells that were preferentially labeled with the fluorescent nucleotide (Fig. 5C, iv-vi). The labeled chromatin in these cells was condensed, and apoptotic bodies were evident. EC exposed to LPS in the presence of Z-VAD (Fig. 5C, iii), Z-VAD alone (Fig. 5C, ii), or medium (Fig. 5C, i) displayed no fluorescent signal.


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 5.   Caspase inhibition protects against LPS-induced protein cleavage and apoptosis. EC were incubated for 4 h with medium, caspase inhibitor (Z-VAD; 100 µM), LPS (100 ng/ml), LPS in the presence of increasing concentrations of Z-VAD, or LPS in the presence of Z-FA (100 µM), a negative control (NC) peptide (A). The caspase inhibitor or negative control peptide was introduced 2 h prior to and throughout the 4-h LPS exposure. EC lysates were immunoblotted with antibodies raised against beta -catenin, gamma -catenin, or FAK. Each blot is representative of three separate experiments. Apoptosis was detected by DNA laddering (B) and TUNEL staining (C). EC were incubated for 4 h with medium, caspase inhibitor (Z-VAD; 100 µM), LPS (100 ng/ml), or LPS with Z-VAD. EC DNA was electrophoresed through a 2% agarose gel stained with ethidium bromide (B). Bands were visualized with ultraviolet light. DNA molecular weight markers, expressed as bp, are indicated to the left. In other experiments, EC monolayers were fixed, permeabilized, and assessed for apoptosis by the TUNEL assay (C) (i, medium control; ii, Z-VAD; iii, LPS with Z-VAD; and iv-vi, LPS alone). Arrows and arrowheads indicate apoptotic bodies and condensed nuclear chromatin, respectively. Magnification, × 450.

Effect of Caspase Inhibition on LPS-induced Disruption of the Endothelial Monolayer-- Since caspase inhibition protected against LPS-induced cleavage of ZA proteins, the ability of Z-VAD to block LPS-induced increments in [14C]BSA was studied (Fig. 6). At concentrations that could block both LPS-induced apoptosis and cleavage of FA and ZA proteins, the caspase inhibitor, Z-VAD (100 µM), did not abrogate LPS-induced loss of barrier function. Since LPS-induced opening of the endothelial paracellular pathway can be blocked by protein tyrosine kinase (PTK) inhibition (6), we studied whether PTK inhibition with herbimycin A could also block LPS-induced cleavage events. Herbimycin A (1 µM) protected against LPS-induced increments in [14C]BSA flux (Fig. 6) but did not block cleavage of adherens junction proteins (Fig. 6, inset).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of caspase inhibition on LPS-induced increments in transendothelial albumin flux. Vertical bars represent mean (±S.E.) transendothelial [14C]BSA flux in pmol/h immediately after a 4-h exposure to medium, Z-VAD (100 µM), herbimycin A (Herb A; 1 µM), LPS (100 ng/ml), LPS + Z-VAD, and LPS + herbimycin A. For all studies, Z-VAD and herbimycin A were introduced 2 and 16 h, respectively, prior to and throughout the LPS challenge. *, significantly increased compared with media alone; **, significantly decreased compared with LPS alone but not significantly increased compared with media alone. n for each experimental group is indicated in each bar. In other experiments, EC seeded on cell culture dishes were treated identically as above and immunoblotted with anti-beta -catenin antibodies (inset). Each lane number in brackets corresponds with the same number and treatment under each vertical bar. The blot is representative of three separate experiments.

Influence of beta -Catenin Cleavage on Its Protein-Protein Interactions-- As a first test as to whether beta -catenin cleavage affected sequences that are established binding sites for beta -catenin-binding proteins, antibodies raised against either the COOH terminus (amino acids 571-781) or the NH2 terminus (amino acids 6-138) were used to probe blots of lysates of EC exposed to LPS (100 ng/ml; 6 h) or medium alone (Fig. 7A). The antibody directed against the NH2 terminus failed to recognize the 70-kDa fragment, localizing the cleavage site(s) to the NH2 terminus. IP of alpha -catenin, which binds to the NH2 terminus of beta -catenin, or IP of cadherin or APC, both of which bind to the COOH terminus of beta -catenin, co-immunoprecipitated both the full-length and truncated forms of beta -catenin (Fig. 7B). alpha -Catenin and cadherin each also bound the two gamma -catenin cleavage products (data not shown).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of LPS-induced beta -catenin cleavage on beta -catenin-protein interactions. Lysates of EC exposed for 6 h to LPS (100 ng/ml; +) or medium alone (-) were immunoblotted with anti-beta -catenin antibodies raised against either the COOH- or NH2 terminus (A). In other experiments, lysates of EC similarly exposed to LPS or medium alone were incubated with anti-cadherin, anti-alpha -catenin, or anti-APC antibodies followed by anti-mouse or anti-rabbit IgG cross-linked to agarose (B). The immunoprecipitated proteins were resolved by SDS-PAGE, transferred to polyvinylidene fluoride membrane, and immunoblotted with an antibody raised against the COOH terminus of beta -catenin. The left panel represents whole cell lysates probed with anti-beta -catenin antibody. Each blot is representative of three separate experiments.

Effect of Caspase Inhibition on LPS-induced EC Detachment-- Since caspase inhibition blocked cleavage of FA proteins, the ability of the caspase inhibitor peptide to block LPS-induced EC detachment was studied (Fig. 8). Introduction of Z-VAD (100 µM) protected against LPS-induced (100 ng/ml; 4 h) EC detachment (Fig. 8A) as well as morphological changes associated with apoptosis (Fig. 8B). The PTK inhibitor, herbimycin A (1 µM), conferred only partial protection against LPS-induced detachment (Fig. 8A). EC exposed to LPS (100 ng/ml, 4 h) displayed widespread cell rounding and detachment from the underlying substrate (Fig. 8B, v). These changes were diminished by the Z-VAD peptide (100 µM) (Fig. 8B, vi) and to a lesser extent by herbimycin A (1 µM) (Fig. 8B, vii) but not by the negative control peptide, Z-FA (100 µM) (Fig. 8B, viii).


View larger version (86K):
[in this window]
[in a new window]
 
Fig. 8.   Caspase inhibition protects against LPS-induced EC detachment. A, vertical bars represent mean (±S.E.) percent EC detachment from gelatin-impregnated filters immediately after a 4-h exposure to medium, Z-VAD (100 µM), herbimycin A (Herb A; 1 µM), LPS (100 ng/ml), LPS + Z-VAD, or LPS + herbimycin A. For all studies, Z-VAD and Herb A were introduced 2 and 16 h, respectively, prior to and throughout the LPS challenge. *, significantly increased compared with medium alone; **, significantly decreased compared with LPS alone but not significantly increased compared with medium alone; ***, significantly decreased compared with LPS alone and significantly increased compared with medium alone. n for each experimental group is indicated in each bar. B, in other studies, ECs cultured in plastic dishes were incubated for 4 h with (i) medium, (ii) Z-VAD (100 µM), (iii) herbimycin A (1 µM), (iv) a control peptide, Z-FA (100 µM), (v) LPS alone (100 ng/ml), (vi) LPS + Z-VAD, (vii) LPS + herbimycin A, or (viii) LPS + Z-FA and then visualized by phase contrast microscopy. Magnification, × 35.

Influence of FAK Cleavage on Its Protein-Protein Interactions-- FAK, a PTK localized to specialized areas of cell-substrate adhesion, binds to and tyrosine phosphorylates another FA protein, paxillin (39, 40). IP of paxillin co-immunoprecipitated full-length FAK but not the cleavage product (Fig. 9A). The anti-FAK antibody that recognizes both the full-length FAK and its cleavage product binds to the region of FAK (amino acids 354-533) that contains its catalytic domain. Paxillin binds to the COOH terminus of FAK (amino acids 919-1042). These findings indicate that LPS-induced cleavage of FAK leads to the disassociation of paxillin from the kinase domain of FAK. We then wanted to determine whether this disassociation affected the tyrosine phosphorylation state of paxillin. In EC incubated with LPS (100 ng/ml) for increasing exposure times, tyrosine phosphorylation of paxillin decreased over time, whereas in medium controls it remained constant (Fig. 9B). This LPS-induced decrease in tyrosine phosphorylation of paxillin was prevented by co-administration of the caspase inhibitor, Z-VAD (100 µM) (Fig. 9C). LPS exposures of >= 4 h decreased tyrosine phosphorylation of paxillin compared with the simultaneous medium controls, and at 6 h, the Z-VAD peptide conferred ~90% protection against this decrease (Fig. 9D).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of FAK cleavage on its association with and tyrosine phosphorylation of paxillin. Lysates of EC exposed for 6 h to LPS (100 ng/ml; +) or medium alone (-) were immunoprecipitated with anti-paxillin antibodies and immunoblotted with a murine monoclonal antibody raised against FAK (A). The left two lanes represent whole cell lysates probed with anti-FAK antibody. In other experiments, paxillin was immunoprecipitated from lysates of EC after increasing exposure times to LPS (100 ng/ml; +) or media alone (-) (B) or to EC treated for 6 h with LPS (100 ng/ml) or medium, in the presence or absence of Z-VAD (100 µM) (C). Blots of these paxillin immunoprecipitates were probed with biotinylated anti-phosphotyrosine antibody (4G10). All blots (A, B, and C) were stripped and reprobed for paxillin (*IB). Laser densitometry to quantitate B and C is shown (D). Each blot is representative of three separate experiments.

The Lipid A Portion of LPS Induces Cleavage of the ZA and FA Proteins-- LPS, as the name implies, is composed of both lipid and polysaccharide components (41). We have previously demonstrated that the lipid A component of LPS is the bioactive portion responsible for inducing EC barrier dysfunction (7). To determine whether lipid A also induces cleavage of adherens junction proteins, we co-administered LPS with either PMB or ENP, two structurally distinct proteins that bind to and neutralize lipid A (7) (Fig. 10A). At concentrations that completely block LPS-induced increments in [14C]BSA flux, ENP (1 µg/ml) and PMB (10 µg/ml) were able to protect against LPS-induced cleavage of p130Cas, FAK, beta -catenin, and gamma -catenin (Fig. 10A and data not shown).


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 10.   LPS-induced EC protein cleavage is blocked by lipid A neutralizing proteins and mimicked by EC exposure to either SEB or TNF-alpha . EC were incubated for 4 h with medium, ENP (1 µg/ml), PMB (10 µg/ml), LPS (100 ng/ml), or LPS in the presence of ENP or PMB (A). In other experiments, EC were incubated for 4 h with either media, LPS (100 ng/ml), SEB (100 µg/ml), or TNF-alpha (500 units/ml) (B). EC lysates were immunoblotted with either anti-beta -catenin or anti-FAK antibodies. Each blot is representative of three separate experiments.

SEB and TNF-alpha Also Induce Cleavage of ZA and FA Component Proteins-- To determine whether cleavage of EC adherens junction proteins was specific to LPS, we incubated EC with concentrations of either SEB (100 µg/ml) or TNF-alpha (500 units/ml) which induce comparable barrier dysfunction to that seen with 100 ng/ml LPS (Fig. 10B). Both agonists were able to induce identical cleavage of p130Cas, FAK, beta -catenin, and gamma -catenin (Fig. 10B and data not shown).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this report, EC monolayers cultured on ECM-coated filters were used in two parallel experimental systems to demonstrate comparable dose and time requirements for LPS-induced increments in transendothelial [14C]BSA flux and EC detachment. Our present and previous studies as well as studies by other investigators have demonstrated that LPS concentrations of >= 10 ng/ml and LPS exposure times of >= 2 h are required to induce a wide range of EC responses including actin reorganization, intercellular gap formation, loss of barrier function, and EC detachment (8, 9, 13-15). Although this 2-h stimulus-to-response lag time is sufficient for new protein synthesis to occur, neither LPS-induced barrier dysfunction (8) nor EC detachment (15) was blocked by prior protein synthesis inhibition. Furthermore, the time requirements for the LPS-induced loss of barrier function are not unlike those described after recombinant TNF-alpha (42, 43), interleukin-1 (44), or SEB (45) exposures.

LPS-induced loss of barrier function and EC detachment occurred at LPS concentrations and exposure times that failed to induce any detectable cytotoxicity as measured by either trypan blue exclusion or lactate dehydrogenase release (8, 9, 15). In the present studies, EC apoptosis as measured by DNA laddering, TUNEL staining, and caspase-mediated proteolysis could be detected after LPS exposures as brief as 2 h. Using the more sensitive 51Cr-release assay, small but consistent increases in 51Cr release could be demonstrated only after exposures of >= 4 h (9, 15). Interestingly, LPS-induced opening of the paracellular pathway and EC detachment each precede 51Cr release (9, 15). The detection of 51Cr release following prolonged LPS exposures may reflect the later stages of apoptosis when plasma membrane integrity is often compromised (46).

LPS-induced proteolysis was selective for certain ZA and FA proteins. The ZA components, beta - and gamma -catenin, were cleaved, whereas alpha -catenin, p120Cas, and cadherin were not. The two substrates for activated caspases are both members of the Armadillo family of proteins and share 65% sequence homology (47, 48). Although a cleavage product could not be detected for p120Cas, a more distantly related member of the Armadillo family, its total relative abundance inconsistently decreased with increasing LPS exposure times. Of the FA proteins studied, only FAK and p130Cas were cleaved. To our knowledge, this is the first time that p130Cas has been identified as a substrate for caspases.

The cleavage of all four proteins was inhibited in a dose-dependent manner by the cell-permeable, irreversible caspase inhibitor, Z-VAD. Asp in the P1 position of the peptide confers specificity for caspases; its lack of an amino acid in the P4 position permits inhibitory activity for several caspase family members (36). Z-VAD has been previously reported to block Fas-induced apoptosis, caspase 1 activity, and activation of caspase 3 (36, 37). A peptide reported to inhibit the cysteine protease, cathepsin B (38), failed to completely block LPS-induced cleavage events. Other protease inhibitors, including those directed against trypsin, serine, thiol, and aspartic proteases, have previously been reported to be ineffective in blocking LPS-induced EC injury and detachment (15). The Z-VAD peptide was also able to abrogate LPS-induced EC DNA laddering and TUNEL staining at the same concentration that blocked caspase-mediated cleavage events. Recently, a DNase that degrades DNA during apoptosis has been shown to be activated following caspase cleavage of its inhibitor (49). Therefore, it is not surprising that caspase inhibition also blocks LPS-induced DNA fragmentation and morphological changes within the nucleus.

Since caspase inhibition could block LPS-induced cleavage of ZA and FA proteins, we investigated whether it also blocked two LPS-induced EC responses that reflect EC-EC and EC-ECM integrity, barrier dysfunction, and EC detachment, respectively. The Z-VAD peptide did not block LPS-induced increments in transendothelial [14C]BSA flux. We have previously reported that PTK inhibition protects against LPS-induced actin depolymerization, opening of the paracellular pathway, and loss of barrier function (6). The mechanism(s) of protection and the phosphoprotein(s) that participate in LPS-induced barrier dysfunction remain unknown. Herbimycin A blocked transendothelial [14C]BSA flux but not cleavage of adherens junction proteins. In addition, LPS treatment of human pulmonary artery EC, which are more resistant to LPS-induced injury (50), resulted in barrier dysfunction in the absence of detectable protein cleavage.2 In contrast, EC detachment was completely blocked by caspase inhibition, whereas PTK inhibition only provided partial protection. That PTK inhibition protects against LPS-induced barrier dysfunction but not protein cleavage, whereas caspase inhibition blocks proteolysis and EC detachment but not barrier dysfunction, suggests that LPS-induced EC detachment and barrier dysfunction are mediated through distinct pathways. Whether the ability of PTK inhibition to partially protect against EC detachment is mediated through the preservation of intercellular adherens junctions remains unknown.

The functional impact of LPS-induced cleavage events on protein-protein interactions was studied (Fig. 11). Antibodies raised against the NH2 terminus of beta -catenin failed to recognize the lower molecular mass band demonstrating that the truncated form lacked the NH2 terminus. The alpha -catenin-binding site on beta -catenin has been localized to amino acids 120-151 in the NH2 terminus (51), and the cadherin and APC-binding sites are located in the COOH-terminal Armadillo repeats (52). It was anticipated that APC and cadherin could bind to the lower molecular mass cleavage product of beta -catenin. Unexpectedly, alpha -catenin also bound to the cleavage product suggesting that the caspase cleavage site is proximal to the alpha -catenin-binding site. NH2-terminal deletion mutants of beta -catenin lacking amino acids 1-89 retain normal binding to both cadherin and alpha -catenin (53). Recently, growth factor deprivation has been shown to induce caspase-mediated cleavage of EC beta -catenin into successively smaller fragments over time (33). Those fragments that appeared at 4 h still bound to alpha -catenin, whereas the smallest fragment which only appeared after 8 h did not. In serum-starved fibroblasts, Brancolini et al. (34) described a beta -catenin cleavage product that displayed decreased binding to alpha -catenin. Although beta -catenin cleavage occurred as early as 2 h, the decreased association of beta - and alpha -catenins was reported only after 12 h. LPS-induced beta -catenin cleavage, barrier dysfunction, and EC detachment were each detectable at <=  4h when ZA multiprotein complex integrity was maintained. It is conceivable that prolonged LPS exposure generates smaller beta -catenin fragments unable to bind alpha -catenin or to couple the ZA to the actin cytoskeleton. Two previous studies have presented evidence for the existence of multiple caspase cleavage sites within beta -catenin, some of which differ in their specificity for various caspase family members (33, 34). Furthermore, one recent report has shown that distinct inducers of apoptosis differ in their ability to promote caspase-mediated cleavage of a given substrate (54). That apoptosis induced by LPS exposure and growth factor withdrawal each activates caspases which differentially cleave beta -catenin is not surprising. Although disruption of beta -catenin-protein interactions was not detected, this does not necessarily mean cell-cell adhesion remained competent. A human gastric cancer cell line expressing mutant beta -catenin with an NH2-terminal deletion of amino acids 28-134 retained its ability to bind alpha -catenin and cadherin (55). However, these cells displayed reduced intercellular adhesion that was restored upon expression of full-length beta -catenin. As EC approach confluence and form stable ZA junctions, gamma -catenin replaces beta -catenin as the protein linking cadherin to alpha -catenin (56). Our findings that gamma -catenin is a substrate for caspase-mediated proteolysis and that its cleavage products retain the ability to bind alpha -catenin are in agreement with a previous study (33).


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 11.   Hypothetical schema for LPS-induced disruption of endothelial monolayer integrity. LPS-induced loss of endothelial barrier function and EC detachment may be mechanistically linked to the activation of PTKs and/or caspases. LPS induces the activation of EC PTKs and a transient state of increased protein tyrosine phosphorylation. PTK inhibition protects against LPS-induced intercellular gap formation, actin depolymerization, and loss of barrier function. LPS also activates caspases that cleave the zonula adherens proteins, beta - and gamma -catenin, as well as the focal adhesion proteins, focal adhesion kinase (FAK) and p130Cas. The cleavage of beta - and gamma -catenin does not appear to alter their binding to alpha -catenin. Cleavage of FAK leads to the dissociation of its kinase domain from another focal adhesion constituent protein and FAK substrate, paxillin, resulting in decreased tyrosine phosphorylation of the latter. This may, in turn, disrupt the ability of focal adhesions to participate in cell adherence to the underlying extracellular matrix and/or disrupt integrin-mediated, cell-survival signaling.

In contrast to beta - and gamma -catenin proteolysis, FAK cleavage resulted in its inability to associate with at least one other protein, paxillin. The FAK cleavage product, which contains the catalytic kinase domain, was unable to associate with paxillin which binds to the COOH terminus of FAK. Compatible with these findings, two distinct caspase cleavage sites have been identified between the kinase domain and the FA targeting domain, the latter of which overlaps with the paxillin-binding site (30, 31). Since FAK phosphorylates paxillin on Tyr-118, in vitro (40), we studied whether the state of paxillin tyrosine phosphorylation was affected by FAK cleavage. We have previously shown increased tyrosine phosphorylation of paxillin in EC following a brief LPS exposure (<= 1 h) (6, 7) temporally proximal to the caspase-mediated FAK cleavage described here. LPS exposure times (>= 2 h) that resulted in FAK cleavage and EC detachment were associated with a time-dependent decrease in the state of paxillin tyrosine phosphorylation. Moreover, this decrease was blocked by caspase inhibition. Therefore, caspase-mediated cleavage of FAK leads to dissociation of its catalytic domain from paxillin resulting in a decreased state of paxillin tyrosine phosphorylation. Evidence exists that tyrosine phosphorylation of FA proteins, including paxillin, is important for FA formation and cell attachment (25, 57-60). First, adherent cells have increased phosphotyrosine-containing proteins localized to the FA (58), and more specifically, tyrosine phosphorylation of FAK and paxillin increases as cells adhere to the underlying ECM (57). Second, PTK inhibition blocks FA formation (57). Finally, overexpression of a protein tyrosine phosphatase prevents cell spreading and FA formation (59), whereas protein tyrosine phosphatase inhibition promotes FAK and paxillin tyrosine phosphorylation, stress fiber formation, and FA assembly (60).

Increasing evidence suggests that FA integrity and cell adhesion are necessary for cell survival (61, 62). Integrins not only activate many signaling pathways associated with cell proliferation, their activation has also been reported to be anti-apoptotic (61-63). Ligation of the alpha vbeta 3 integrin, the primary integrin found in mature EC FA, promotes cell survival through suppression of the bax-induced apoptosis pathway (64), and in proliferating EC, alpha vbeta 3 antagonism induces apoptosis (65). Since integrin engagement and/or activation are vital for cell survival, disruption of the structural and/or signaling elements that couple integrins to the cell interior may arrest cell proliferation and promote apoptosis. In fact, displacement of endogenous FAK from FA by microinjection of a FAK mutant that contains the FA-targeting COOH terminus but lacks the catalytic kinase domain diminishes serum-induced DNA synthesis (66). Interestingly, caspase-mediated cleavage of FAK generates a COOH-terminal fragment not unlike the above mentioned COOH-terminal construct which competes with FAK for binding to the FA complex (31, 66). Finally, reduction of cellular levels of FAK with antisense oligonucleotides induces cell detachment and apoptosis (67).

The LPS molecule, as the name implies, is composed of a lipid conjugated to a polysaccharide chain. Lipid A has previously been shown to be the active portion of the LPS molecule capable of stimulating CD14-bearing cells (68) as well as the non-CD14-bearing EC (7). PMB and ENP, derived from the bacterium Bacillus polymyxa and the horseshoe crab Limulus polyphemus, respectively, both bind to and neutralize the lipid A portion of LPS and block several LPS-induced EC responses (7). In the present report, we found that preadsorption with either agent protected against LPS-induced cleavage of all four adherens junction proteins. Thus, lipid A, a lipid that is novel in nature, induces EC caspase activation. Although these findings might have suggested that such proteolytic events during septic processes were limited to LPS exposure, the same cleavage events were clearly evoked by other agents as well. SEB, which is derived from the Gram-positive organism, Staphylococcus aureus, and TNF-alpha , an established mediator of the acute phase response to injury that is elevated during both Gram-negative and Gram-positive bacterial infections, each were able to induce cleavage of the same four adherens junction proteins cleaved following exposure to LPS. The cleavage products generated by proteolysis of all four proteins were of the same molecular mass as those detected following LPS exposure. These combined data suggest that cleavage of adherens junction proteins and disruption of tyrosine phosphorylation signaling events occur in response to diverse apoptotic stimuli. Furthermore, the elevated levels of TNF-alpha observed during sepsis may synergistically enhance the sensitivity of EC to LPS- and/or SEB-induced apoptosis.

In summary, LPS induces caspase activation, cleavage of ZA and FA proteins, barrier dysfunction, and EC detachment, all at comparable doses and exposure times. There was no evidence of disruption of either ZA protein-protein interactions or loss of barrier function as a result of caspase-mediated proteolysis. Cleavage of FAK, however, resulted in the dissociation of its catalytic kinase domain from the FA protein, paxillin, and a resultant decrease in the level of paxillin tyrosine phosphorylation. These events were blocked by caspase inhibition which also blocked EC detachment. These findings suggest a bifurcation in the pathways through which LPS influences cell-cell adhesion and the endothelial paracellular pathway versus EC adhesion to the underlying ECM. Finally, these findings have ramifications for more than Gram-negative septic processes as other exogenous and endogenous mediators can induce similar protein cleavage events.

    FOOTNOTES

* This work was supported in part by the Office of Research and Development, Department of Veterans Affairs, and U. S. Army Medical Research and Development Command Grant DAMD 17-91-Z-1004.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of the Department of Defense Augmentation Award for Science and Engineering Research Training.

§ To whom correspondence should be addressed: Medical Service (111), Rm. 5D-139, Dept. of Veterans Affairs Medical Center, 10 N. Greene St., Baltimore, MD 21201. Tel.: 410-605-7182; Fax: 410-605-7914.

The abbreviations used are: EC, endothelial cell(s); LPS, lipopolysaccharide; ECM, extracellular matrix; ZA, zonula adherens; FA, focal adhesion; FAK, focal adhesion kinase; TNF-alpha , tumor necrosis factor alpha ; PMB, polymyxin B; SEB, staphylococcal enterotoxin B; Me2SO, dimethyl sulfoxide; ENP, endotoxin neutralizing protein; FBS, fetal bovine serum; DMEM, Dulbecco's modified Eagle's medium; BSA, bovine serum albumin; RIPA, radioimmunoprecipitation assay; IgG, immunoglobulin G; IP, immunoprecipitation; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; PTK, protein tyrosine kinase; bp, base pairs; APC, familial adenomatous polyposis coli gene product; Z-, benzyloxycarbonyl-.

2 D. D. Bannerman, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Brigham, K. L., and Meyrick, B. (1986) Am. Rev. Respir. Dis. 133, 913-927[Medline] [Order article via Infotrieve]
  2. Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S., and Sorensen, E. (1989) J. Infect. Dis. 159, 195-204[Medline] [Order article via Infotrieve]
  3. Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M., and Parillo, J. E. (1991) Chest 99, 169-175[Abstract/Free Full Text]
  4. Ulevitch, R. J., Cochrane, C. G., Henson, P. M., Morrison, D. C., and Doe, W. F. (1975) J. Exp. Med. 142, 1570-1590[Abstract/Free Full Text]
  5. Desch, C. E., O'Hara, P., and Harlan, J. M. (1989) Infect. Immun. 57, 1612-1614[Abstract/Free Full Text]
  6. Bannerman, D. D., and Goldblum, S. E. (1997) Am. J. Physiol. 273, L217-L226[Abstract/Free Full Text]
  7. Bannerman, D. D., Fitzpatrick, M. J., Anderson, D. Y., Bhattacharjee, A. K., Novitsky, T. J., Hasday, J. D., Cross, A. S., and Goldblum, S. E. (1998) Infect. Immun. 66, 1400-1407[Abstract/Free Full Text]
  8. Goldblum, S. E., Ding, X., Brann, T. W., and Campbell-Washington, J. (1993) J. Cell. Physiol. 157, 13-23[CrossRef][Medline] [Order article via Infotrieve]
  9. Goldblum, S. E., Brann, T. W., Ding, X., Pugin, J., and Tobias, P. S. (1994) J. Clin. Invest. 93, 692-702
  10. Rubenstein, H. S., Fine, J., and Coons, A. H. (1962) Proc. Soc. Exp. Biol. Med. 111, 458-467
  11. Redl, H., Schlag, G., Kneidinger, R., Ohlinger, W., and Davies, J. (1994) Arzneim. Forsch. 44, 443-446[Medline] [Order article via Infotrieve]
  12. Olson, N. C., Hellyer, P. W., and Dodam, J. R. (1995) Br. Vet. J. 151, 489-522[Medline] [Order article via Infotrieve]
  13. Meyrick, B. O., Ryan, U. S., and Brigham, K. L. (1986) Am. J. Pathol. 122, 140-151[Abstract]
  14. Meyrick, B. O. (1986) Fed. Proc. 45, 19-24[Medline] [Order article via Infotrieve]
  15. Harlan, J. M., Harker, L. A., Reidy, M. A., Gajdusek, C. M., Schwartz, S. M., and Striker, G. E. (1983) Lab. Invest. 48, 269-274[Medline] [Order article via Infotrieve]
  16. Paulsen, D. B., Mosier, D. A., Clinkenbeard, K. D., and Confer, A. W. (1989) Am. J. Vet. Res. 50, 1633-1637[Medline] [Order article via Infotrieve]
  17. Dejana, E., Corada, M., and Lampugnani, M. G. (1995) FASEB J. 9, 910-918[Abstract]
  18. Dejana, E., and Del Maschio, A. (1995) Thromb. Haemostasis 74, 309-312[Medline] [Order article via Infotrieve]
  19. Burridge, K., Fath, K., Kelly, T., Nuckolls, G., and Turner, C. (1988) Annu. Rev. Cell Biol. 4, 487-525[CrossRef]
  20. Woods, A., and Couchman, J. R. (1988) Collagen Relat. Res. 8, 155-182
  21. Aberle, H., Schwartz, H., and Kemler, R. (1996) J. Cell. Biochem. 61, 514-523[CrossRef][Medline] [Order article via Infotrieve]
  22. Barth, A. I., Nathke, I. S., and Nelson, W. J. (1997) Curr. Opin. Cell Biol. 9, 683-690[CrossRef][Medline] [Order article via Infotrieve]
  23. Dejana, E. (1996) J. Clin. Invest. 98, 1949-1953[Medline] [Order article via Infotrieve]
  24. Albelda, S. M. (1991) Am. J. Respir. Cell Mol. Biol. 4, 195-203
  25. Turner, C. E. (1994) BioEssays 16, 47-52[CrossRef][Medline] [Order article via Infotrieve]
  26. Choi, K. B., Wong, F., Harlan, J. M., Chaudhary, P. M., Hood, L., and Karsan, A. (1998) J. Biol. Chem. 273, 20185-20188[Abstract/Free Full Text]
  27. Frey, E. A., and Finlay, B. B. (1998) Microb. Pathog. 24, 101-109[CrossRef][Medline] [Order article via Infotrieve]
  28. HaimovitZ-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., III, Schuchman, E. H., Fuks, Z., and Kolesnick, R. (1997) J. Exp. Med. 186, 1831-1841[Abstract/Free Full Text]
  29. Schumann, R. R., Belka, C., Reuter, D., Lamping, N., Kirschning, C. J., Weber, J. R., and Pfeil, D. (1998) Blood 91, 577-584[Abstract/Free Full Text]
  30. Wen, L. P., Fahrni, J. A., Troie, S., Guan, J. L., Orth, K., and Rosen, G. D. (1997) J. Biol. Chem. 272, 26056-26061[Abstract/Free Full Text]
  31. Gervais, F. G., Thornberry, N. A., Ruffolo, S. C., Nicholson, D. W., and Roy, S. (1998) J. Biol. Chem. 273, 17102-17108[Abstract/Free Full Text]
  32. Levkau, B., Herren, B., Koyama, H., Ross, R., and Raines, E. W. (1998) J. Exp. Med. 187, 579-586[Abstract/Free Full Text]
  33. Herren, B., Levkau, B., Raines, E. W., and Ross, R. (1998) Mol. Biol. Cell 9, 1589-1601[Abstract/Free Full Text]
  34. Brancolini, C., Lazarevic, D., Rodriguez, J., and Schneider, C. (1997) J. Cell Biol. 139, 759-771[Abstract/Free Full Text]
  35. Salomon, R. N., and Diaz-Cano, S. (1995) Diagn. Mol. Pathol. 4, 235-238[Medline] [Order article via Infotrieve]
  36. Armstrong, R. C., Aja, T., Xiang, J., Gaur, S., Krebs, J. F., Hoang, K., Bai, X., Korsmeyer, S. J., Karanewsky, D. S., Fritz, L. C., and Tomaselli, K. J. (1996) J. Biol. Chem. 271, 16850-16855[Abstract/Free Full Text]
  37. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W., and Cohen, G. M. (1996) Biochem. J. 315, 21-24
  38. Rauber, P., Angliker, H., Walker, B., and Shaw, E. (1986) Biochem. J. 239, 633-640[Medline] [Order article via Infotrieve]
  39. Schaller, M. D., and Parsons, J. T. (1994) Curr. Opin. Cell Biol. 6, 705-710[CrossRef][Medline] [Order article via Infotrieve]
  40. Bellis, S. L., Miller, J. T., and Turner, C. E. (1995) J. Biol. Chem. 270, 17437-17441[Abstract/Free Full Text]
  41. Rietschel, E. T., Kirikae, T., Schade, F. U., Ulmer, A. J., Holst, O., Brade, H., Schmidt, G., Mamat, U., Grimmecke, H. D., Kusumoto, S., and Hringer, U. (1993) Immunobiology 187, 169-190[Medline] [Order article via Infotrieve]
  42. Goldblum, S. E., and Sun, W. L. (1990) Am. J. Physiol. 258, L57-L67[Abstract/Free Full Text]
  43. Goldblum, S. E., Hennig, B., Jay, M., Yoneda, K., and McClain, C. J. (1989) Infect. Immun. 57, 1218-1226[Abstract/Free Full Text]
  44. Campbell, W. N., Ding, X., and Goldblum, S. E. (1992) Am. J. Physiol. 263, L128-L136[Abstract/Free Full Text]
  45. Campbell, W. N., Fitzpatrick, M., Ding, X., Jett, M., Gemski, P., and Goldblum, S. E. (1997) Am. J. Physiol. 273, L31-L39[Abstract/Free Full Text]
  46. Kroemer, G., Petit, P., Zamzami, N., Vayssiere, J. L., and Mignotte, B. (1995) FASEB J. 9, 1277-1287[Abstract]
  47. Butz, S., Stappert, J., Weissig, H., and Kemler, R. (1992) Science 257, 1142-1144[Free Full Text]
  48. McCrea, P. D., Turck, C. W., and Gumbiner, B. (1991) Science 254, 1359-1361[Abstract/Free Full Text]
  49. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998) Nature 391, 43-50[CrossRef][Medline] [Order article via Infotrieve]
  50. Harlan, J. M., Harker, L. A., Striker, G. E., and Weaver, L. J. (1983) Thromb. Res. 29, 15-26[CrossRef][Medline] [Order article via Infotrieve]
  51. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R., and Hoschuetzky, H. (1994) J. Cell Sci. 107, 3655-3663[Abstract]
  52. Hulsken, J., Birchmeier, W., and Behrens, J. (1994) J. Cell Biol. 127, 2061-2069[Abstract/Free Full Text]
  53. Munemitsu, S., Albert, I., Rubinfeld, B., and Polakis, P. (1996) Mol. Cell. Biol. 16, 4088-4094[Abstract]
  54. Widmann, C., Gibson, S., and Johnson, G. L. (1998) J. Biol. Chem. 273, 7141-7147[Abstract/Free Full Text]
  55. Kawanishi, J., Kato, J., Sasaki, K., Fujii, S., Watanabe, N., and Niitsu, Y. (1995) Mol. Cell. Biol. 15, 1175-1181[Abstract]
  56. Lampugnani, M. G., Corada, M., Caveda, L., Breviario, F., Ayalon, O., Geiger, B., and Dejana, E. (1995) J. Cell Biol. 129, 203-217[Abstract/Free Full Text]
  57. Burridge, K., Turner, C. E., and Romer, L. H. (1992) J. Cell Biol. 119, 893-903[Abstract/Free Full Text]
  58. Maher, P. A., Pasquale, E. B., Wang, J. Y., and Singer, S. J. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 6576-6580[Abstract/Free Full Text]
  59. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. (1998) Science 280, 1614-1617[Abstract/Free Full Text]
  60. Retta, S. F., Barry, S. T., Critchley, D. R., Defilippi, P., Silengo, L., and Tarone, G. (1996) Exp. Cell Res. 229, 307-317[CrossRef][Medline] [Order article via Infotrieve]
  61. Burridge, K., and Chrzanowska-Wodnicka, M. (1996) Annu. Rev. Cell Dev. Biol. 12, 463-518[CrossRef][Medline] [Order article via Infotrieve]
  62. Ruoslahti, E. (1997) Science 276, 1345-1346[Free Full Text]
  63. Guan, J. L. (1997) Int. J. Biochem. Cell Biol. 29, 1085-1096[CrossRef][Medline] [Order article via Infotrieve]
  64. Stromblad, S., Becker, J. C., Yebra, M., Brooks, P. C., and Cheresh, D. A. (1996) J. Clin. Invest. 98, 426-433[Medline] [Order article via Infotrieve]
  65. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Cell 79, 1157-1164[CrossRef][Medline] [Order article via Infotrieve]
  66. Gilmore, A. P., and Romer, L. H. (1996) Mol. Biol. Cell 7, 1209-1224[Abstract]
  67. Xu, L. H., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. (1996) Cell Growth Differ. 7, 413-418[Abstract]
  68. Ulevitch, R. J., and Tobias, P. S. (1995) Annu Rev Immunol 13, 437-57[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Karahashi, K. S. Michelsen, and M. Arditi
Lipopolysaccharide-Induced Apoptosis in Transformed Bovine Brain Endothelial Cells and Human Dermal Microvessel Endothelial Cells: The Role of JNK
J. Immunol., June 1, 2009; 182(11): 7280 - 7286.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Le, R. Damico, M. Damarla, A. Boueiz, H. H. Pae, J. Skirball, E. Hasan, X. Peng, A. Chesley, M. T. Crow, et al.
Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury
J Appl Physiol, October 1, 2008; 105(4): 1282 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Ramchandran, D. Mehta, S. M. Vogel, M. K. Mirza, P. Kouklis, and A. B. Malik
Critical role of Cdc42 in mediating endothelial barrier protection in vivo
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L363 - L369.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Liu, R. Yang, B. Tinner, A. Choudhry, N. Schutze, and B. Chaqour
Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes
Endocrinology, April 1, 2008; 149(4): 1666 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-Y. Lee, H.-J. You, J.-Y. Won, S.-W. Youn, H.-J. Cho, K.-W. Park, W.-Y. Park, J.-S. Seo, Y.-B. Park, K. Walsh, et al.
Forkhead Factor, FOXO3a, Induces Apoptosis of Endothelial Cells Through Activation of Matrix Metalloproteinases
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. J. Angelini, S.-W. Hyun, D. N. Grigoryev, P. Garg, P. Gong, I. S. Singh, A. Passaniti, J. D. Hasday, and S. E. Goldblum
TNF-{alpha} increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1232 - L1245.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Sheets, J. Potempa, J. Travis, H. M. Fletcher, and C. A. Casiano
Gingipains from Porphyromonas gingivalis W83 Synergistically Disrupt Endothelial Cell Adhesion and Can Induce Caspase-Independent Apoptosis.
Infect. Immun., October 1, 2006; 74(10): 5667 - 5678.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. G. Nemchinov, M. J. Paape, E. J. Sohn, D. D. Bannerman, D. S. Zarlenga, and R. W. Hammond
Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection
FASEB J, July 1, 2006; 20(9): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Minambres, R. M. Guasch, A. Perez-Arago, and C. Guerri
The RhoA/ROCK-I/MLC pathway is involved in the ethanol-induced apoptosis by anoikis in astrocytes
J. Cell Sci., January 15, 2006; 119(2): 271 - 282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Covington, K. J. Bayless, R. C. Burghardt, G. E. Davis, and A. R. Parrish
Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F280 - F288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig
Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation
J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. F. Sui, T. D. Kiser, S. W. Hyun, D. J. Angelini, R. L. Del Vecchio, B. A. Young, J. D. Hasday, L. H. Romer, A. Passaniti, N. K. Tonks, et al.
Receptor Protein Tyrosine Phosphatase {micro} Regulates the Paracellular Pathway in Human Lung Microvascular Endothelia
Am. J. Pathol., April 1, 2005; 166(4): 1247 - 1258.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Liu, D. Zhang, J. Scafidi, X. Wu, C. C. Cramer, and A. E. Davis III
C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability
Blood, March 15, 2005; 105(6): 2350 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Melendez, C. Turner, H. Avraham, S. F. Steinberg, E. Schaefer, and M. A. Sussman
Cardiomyocyte Apoptosis Triggered by RAFTK/pyk2 via Src Kinase Is Antagonized by Paxillin
J. Biol. Chem., December 17, 2004; 279(51): 53516 - 53523.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Wong, C. Hull, R. Zhande, J. Law, and A. Karsan
Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal
Blood, June 15, 2004; 103(12): 4520 - 4526.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Guo, M. H. Wu, H. J. Granger, and S. Y. Yuan
Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability
J. Physiol., January 1, 2004; 554(1): 78 - 88.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp
Infections and endothelial cells
Cardiovasc Res, October 15, 2003; 60(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Peters, R. E. Unger, J. Brunner, and C.J. Kirkpatrick
Molecular basis of endothelial dysfunction in sepsis
Cardiovasc Res, October 15, 2003; 60(1): 49 - 57.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Franchi, I. Condo, B. Tomassini, C. Nicolo, and R. Testi
A caspaselike activity is triggered by LPS and is required for survival of human dendritic cells
Blood, October 15, 2003; 102(8): 2910 - 2915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. D. Bannerman and S. E. Goldblum
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L899 - L914.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. C. Aird
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Blood, May 15, 2003; 101(10): 3765 - 3777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
I. Petrache, A. Birukova, S. I. Ramirez, J. G. N. Garcia, and A. D. Verin
The Role of the Microtubules in Tumor Necrosis Factor-{alpha}-Induced Endothelial Cell Permeability
Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 574 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Cai, K. N. Felekkis, R. I. Near, G. M. O'Neill, J. M. van Seventer, E. A. Golemis, and A. Lerner
The GDP Exchange Factor AND-34 Is Expressed in B Cells, Associates With HEF1, and Activates Cdc42
J. Immunol., January 15, 2003; 170(2): 969 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. D. Erwert, R. K. Winn, J. M. Harlan, and D. D. Bannerman
Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein Expression Sensitizes Endothelial Cells to Bacterial Lipopolysaccharide-induced Apoptosis
J. Biol. Chem., October 18, 2002; 277(43): 40567 - 40574.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. V. Nyholm, B. Deplancke, H. R. Gaskins, M. A. Apicella, and M. J. McFall-Ngai
Roles of Vibrio fischeri and Nonsymbiotic Bacteria in the Dynamics of Mucus Secretion during Symbiont Colonization of the Euprymna scolopes Light Organ
Appl. Envir. Microbiol., October 1, 2002; 68(10): 5113 - 5122.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Hull, G. McLean, F. Wong, P. J. Duriez, and A. Karsan
Lipopolysaccharide Signals an Endothelial Apoptosis Pathway Through TNF Receptor-Associated Factor 6-Mediated Activation of c-Jun NH2-Terminal Kinase
J. Immunol., September 1, 2002; 169(5): 2611 - 2618.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. de Botton, S. Sabri, E. Daugas, Y. Zermati, J. E. Guidotti, O. Hermine, G. Kroemer, W. Vainchenker, and N. Debili
Platelet formation is the consequence of caspase activation within megakaryocytes
Blood, July 30, 2002; 100(4): 1310 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Munshi, A. Z. Fernandis, R. P. Cherla, I.-W. Park, and R. K. Ganju
Lipopolysaccharide-Induced Apoptosis of Endothelial Cells and Its Inhibition by Vascular Endothelial Growth Factor
J. Immunol., June 1, 2002; 168(11): 5860 - 5866.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Bannerman, J. C. Tupper, R. D. Erwert, R. K. Winn, and J. M. Harlan
Divergence of Bacterial Lipopolysaccharide Pro-apoptotic Signaling Downstream of IRAK-1
J. Biol. Chem., March 1, 2002; 277(10): 8048 - 8053.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. M. O'Neill and E. A. Golemis
Proteolysis of the Docking Protein HEF1 and Implications for Focal Adhesion Dynamics
Mol. Cell. Biol., August 1, 2001; 21(15): 5094 - 5108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Petrache, A. D. Verin, M. T. Crow, A. Birukova, F. Liu, and J. G. N. Garcia
Differential effect of MLC kinase in TNF-{alpha}-induced endothelial cell apoptosis and barrier dysfunction
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1168 - L1178.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-H. Ling, Y. Zhong, and R. Perez-Soler
Disruption of Cell Adhesion and Caspase-Mediated Proteolysis of {beta}- and {gamma}-Catenins and APC Protein in Paclitaxel-Induced Apoptosis
Mol. Pharmacol., March 1, 2001; 59(3): 593 - 603.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
G. Zysk, B. K. Schneider-Wald, J. H. Hwang, L. Bejo, K. S. Kim, T. J. Mitchell, R. Hakenbeck, and H.-P. Heinz
Pneumolysin Is the Main Inducer of Cytotoxicity to Brain Microvascular Endothelial Cells Caused by Streptococcus pneumoniae
Infect. Immun., February 1, 2001; 69(2): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. O. Harrington, A. Smeglin, J. Newton, G. Ballard, and S. Rounds
Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in endothelial cell apoptosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L342 - L353.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Xing, C. Ge, R. Zeltser, G. Maskevitch, B. J. Mayer, and K. Alexandropoulos
c-Src Signaling Induced by the Adapters Sin and Cas Is Mediated by Rap1 GTPase
Mol. Cell. Biol., October 1, 2000; 20(19): 7363 - 7377.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
J.-F. Martini, C. Piot, L. M. Humeau, I. Struman, J. A. Martial, and R. I. Weiner
The Antiangiogenic Factor 16K PRL Induces Programmed Cell Death in Endothelial Cells by Caspase Activation
Mol. Endocrinol., October 1, 2000; 14(10): 1536 - 1549.
[Abstract] [Full Text]


Home page
JCBHome page
J. N. Lavoie, C. Champagne, M.-C. Gingras, and A. Robert
Adenovirus E4 Open Reading Frame 4-induced Apoptosis Involves Dysregulation of Src Family Kinases
J. Cell Biol., September 5, 2000; 150(5): 1037 - 1056.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Albon, A. B. Tullo, S. Aktar, and M. E. Boulton
Apoptosis in the Endothelium of Human Corneas for Transplantation
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2887 - 2893.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
L. Chandrasekaran, C.-Z. He, H. Al-Barazi, H. C. Krutzsch, M. L. Iruela-Arispe, and D. D. Roberts
Cell Contact-dependent Activation of alpha 3beta 1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1
Mol. Biol. Cell, September 1, 2000; 11(9): 2885 - 2900.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. F. Law, G. M. O'Neill, S. J. Fashena, M. B. Einarson, and E. A. Golemis
The Docking Protein HEF1 Is an Apoptotic Mediator at Focal Adhesion Sites
Mol. Cell. Biol., July 15, 2000; 20(14): 5184 - 5195.
[Abstract] [Full Text]


Home page
ChestHome page
T. Stefanec
Endothelial Apoptosis: Could It Have a Role in the Pathogenesis and Treatment of Disease?
Chest, March 1, 2000; 117(3): 841 - 854.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Kook, S. R. Shim, S. J. Choi, J. Ahnn, J. I. Kim, S. H. Eom, Y. K. Jung, S. G. Paik, and W. K. Song
Caspase-mediated Cleavage of p130cas in Etoposide-induced Apoptotic Rat-1 Cells
Mol. Biol. Cell, March 1, 2000; 11(3): 929 - 939.
[Abstract] [Full Text]


Home page
JCBHome page
J. C. Mills, N. L. Stone, and R. N. Pittman
Extranuclear Apoptosis: The Role of the Cytoplasm in the Execution Phase
J. Cell Biol., August 23, 1999; 146(4): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Bannerman, J. C. Tupper, W. A. Ricketts, C. F. Bennett, R. K. Winn, and J. M. Harlan
A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced Apoptosis
J. Biol. Chem., April 27, 2001; 276(18): 14924 - 14932.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bannerman, D. D.
Right arrow Articles by Goldblum, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bannerman, D. D.
Right arrow Articles by Goldblum, S. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement